Vaccine reluctance linked to belief in virus hoaxes, study shows | Malay Mail

Malaysia News News

Vaccine reluctance linked to belief in virus hoaxes, study shows | Malay Mail
Malaysia Latest News,Malaysia Headlines
  • 📰 malaymail
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 86%

LONDON, Oct 15 — Up to a third of people in certain countries may believe coronavirus misinformation and in turn be less open to immunisation, scientists said yesterday, warning that development of a vaccine “might not be enough.” Researchers in Britain and the Netherlands conducted surveys...

Up to a third of people in certain countries may believe coronavirus misinformation and in turn be less open to immunisation, scientists said October 14, 2020. — JurgaR/Istock.com pic via AFP

The World Health Organisation has warned that the pandemic has been accompanied by a damaging “infodemic” that has made it hard for people to cut through the misinformation. The hoax that Covid-19 symptoms are worsened by 5G phone networks was deemed reliable by 16 per cent of respondents in Mexico and in Spain, 12 per cent in Ireland, and 8 per cent in both the UK and US., found “a clear link” between believing coronavirus conspiracies and hesitancy around any future vaccine, said co-author Sander van der Linden, director of the Cambridge University Social Decision-Making Lab.

Jon Roozenbeek, the lead author and a postdoctoral fellow at Cambridge's Department of Psychology, said people were dealing with “a deluge of statistics” in the pandemic. Trusting politicians' ability to tackle the crisis predicted a higher likelihood of believing conspiracies in Mexico, Spain and the US, but not in the UK and Ireland, the study found.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

malaymail /  🏆 1. in MY

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Johnson & Johnson pauses Covid-19 vaccine trials due to unexplained illness in participant | Malay MailJohnson & Johnson pauses Covid-19 vaccine trials due to unexplained illness in participant | Malay MailNEW YORK, Oct 13 — Johnson & Johnson said yesterday it has temporarily paused its Covid-19 vaccine candidate clinical trials due to an unexplained illness in a study participant. The participant's illness is being reviewed and evaluated by an independent data and safety monitoring board as...
Read more »

Hishammuddin: Malaysia to be a priority recipient of China-produced Covid-19 vaccine | Malay MailHishammuddin: Malaysia to be a priority recipient of China-produced Covid-19 vaccine | Malay MailKUALA LUMPUR, Oct 13 — China has agreed to list Malaysia as a priority recipient of the China-produced Covid-19 vaccine once it successfully developed, said Datuk Seri Hishammuddin Tun Hussein. The Foreign Minister announced this in a joint news conference after the bilateral meeting with his...
Read more »

Wall Street retreats after four-day winning streak as J&J vaccine worries weigh | Malay MailWall Street retreats after four-day winning streak as J&J vaccine worries weigh | Malay MailNEW YORK, Oct 13 — Wall Street’s main indexes fell today after a four-day winning streak as a pause in Johnson & Johnson’s Covid-19 vaccine trials spurred concerns about a full economic rebound from the coronavirus-led downturn. Johnson & Johnson raised its annual profit forecast, but...
Read more »

Asian equities set to slip as vaccine trials, stimulus talks stall | Malay MailAsian equities set to slip as vaccine trials, stimulus talks stall | Malay MailSYDNEY, Oct 14 ― Asian equities were set to slip today as halted Covid-19 vaccine trials and an elusive US stimulus agreement weighed on investor sentiment, while the dollar rose from yesterday's three-week low as demand firmed for safe-haven assets. Johnson & Johnson said yesterday that it...
Read more »

Johnson & Johnson moves to buoy investors over paused Covid-19 vaccine trial | Malay MailJohnson & Johnson moves to buoy investors over paused Covid-19 vaccine trial | Malay MailWASHINGTON, Oct 14 ― US pharmaceutical giant Johnson & Johnson sought yesterday to reassure investors after its stock slumped on an announcement that it was pausing a Covid-19 vaccine trial over a sick participant. The company is one of several working on a vaccine, but on Monday it announced...
Read more »

European shares muted on doubts around vaccine trial, lockdowns | Malay MailEuropean shares muted on doubts around vaccine trial, lockdowns | Malay MailLONDON, Oct 14 — European shares steadied today after tumbling in the previous session due to a pause in a Covid-19 vaccine trial and on concerns about more lockdowns, although investors stayed away from big bets ahead of talks on a Brexit trade deal. The pan-European STOXX 600 index was flat by...
Read more »



Render Time: 2025-04-06 02:47:33